fda glp-1 compounding crackdown news issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Compound versions of GLP-1 drugs
Description
Digestive system: nausea, diarrhea, constipation, stomach pain, vomiting
Olubunmi Oladunjoye discusses GLP-1 medications for weight management, including their rise in popularity and possible side effects.
Between-study heterogeneity was very high (I = 99.21%) although sensitivity analysis revealed that the findings were robust
Conclusions GLP-1RA use was not associated with a decreased or increased risk of AF compared to DPP4i use
